Cavitation Technologies, Inc. (CVAT) Stock Price & Analysis
Cavitation Technologies, Inc. (CVAT) — price $0.0289 (-1.37%), as of the Nov 20, 2026 trading session; market cap $9.37M.
Educational signal · not a buy or sell recommendation · How to read this
Cavitation Technologies, Inc. · CVAT
Cavitation Technologies, Inc. develops and commercializes proprietary fluid processing technologies, including Nano Reactor and Nano Neutralization Systems, for diverse industrial and consumer applications. The company's solutions are utilized in sectors such as vegetable oil refining, renewable fuels, water treatment, and crude oil yield enhancement.
Price as of Nov 20, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Thousands of the 20,000+ US stocks here carry a MoonshotScore.
Scored companies in the same industry:
- ATS · ATS Corporation · 61 /100
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.0289 | |
| Change on the day | -1.37% | |
| Market capitalisation | $9.37M | — |
| Shares traded on the day | 109.9K |
Price & events
Other perspectives
Council score for Cavitation Technologies (CVAT): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
4 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 16, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 21, 2026, except a card that shows its own read date.
What is Cavitation Technologies (CVAT), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Cavitation Technologies, Inc. (CVAT) is the company analyzed here. It employs 2 people. In Q3 FY2026 it reported revenue of $3,000 and net income of -$219,000. The market values it at $9.37M.
What do the latest results show for Cavitation Technologies (CVAT)?
Short answer · as of
The most recent reported quarter, Q3 FY2026, carried revenue of $3,000. Against analyst estimates the company has EPS beat 2 of the last 8 reports.
Quarterly income statement — 1 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2026 | $3,000 | -$219,000 | -$0.0007 (diluted) |
What are the financial strengths and risks for Cavitation Technologies (CVAT)?
Short answer · as of
The distress and quality screens read Piotroski F 1. Trailing ratios: ROE 252.3% · current ratio 0.15 · earnings yield -14.1% · free-cash-flow yield -6.8%.
Data-derived red flags
- Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 8 reported quarters.
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
The records behind this page
Insider activity
Form 4 records via FMP · Most recent available transactions
- Transactions
- 12
- Identified insiders
- 2
- Purchases
- 5
- Sales
- 0
- Other transactions
- 7
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held CVAT in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported CVAT in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Cavitation Technologies (CVAT)?
- Cavitation Technologies, Inc. Files Schedule 14D-9; Board Recommends Shareholders Tender Shares in BrightFlixx Cash Tender Offer
- BrightFlixx Finance (Luxembourg) S.A. Commences Cash Tender Offer For All Outstanding Shares of Cavitation Technologies, Inc. and Concurrent Cash Tender Offer For All Outstanding Shares of Alchemy Beverages Inc.
Investor Questions: CVAT Stock
These answers are editorial: 1 of these 8 answers is drawn from the CVAT research dossier (written Jun 14, 2026 by gemini-2.5-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is CVAT a good stock to buy?
Stock Expert AI does not rate CVAT buy, sell or hold. Cavitation Technologies, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the CVAT stock price today?
The last price recorded for Cavitation Technologies, Inc. (CVAT), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What does Cavitation Technologies, Inc. do?
Cavitation Technologies, Inc. specializes in developing, patenting, and commercializing advanced fluid processing technology, primarily its Nano Reactor and Nano Neutralization Systems. For instance, they are used in refining vegetable oils like soybean and palm oil.
What are the key factors to evaluate for CVAT?
Evaluate CVAT on fundamentals, analyst consensus, and risk factors. Cavitation Technologies, Inc. holds proprietary technology for fluid processing, including Nano Reactor and Nano Neutralization Systems, applicable across diverse industrial sectors. Not financial advice.
How frequently does CVAT data refresh on this page?
CVAT's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven CVAT's recent stock price performance?
Cavitation Technologies, Inc. (CVAT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary and patented Nano Reactor and Nano Neutralization Systems for fluid processing. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CVAT overvalued or undervalued right now?
Cavitation Technologies, Inc. (CVAT) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research CVAT before investing?
Before investing in Cavitation Technologies, Inc. (CVAT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 13 figures on this page — 9 from Financial Modeling Prep (FMP) and 4 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com